EN | UA
EN | UA

Help Support

Back

Assessment of cognitive dysfunctions after intensive care in patients with COVID-19

COVID_cognitive_impairment COVID_cognitive_impairment
COVID_cognitive_impairment COVID_cognitive_impairment

A prospective single-center study (CognitiVID) aimed to assess basic cognitive functions following care in intensive care unit (ICU) and after 3 months in post-ICU SARS-CoV-2 infected patients.

See All

Key take away

In COVID-19 patients with short term cognitive impairment, intensive care led to remarkable betterment in their cognition at three months.

Background

A prospective single-center study (CognitiVID) aimed to assess basic cognitive functions following care in intensive care unit (ICU) and after 3 months in post-ICU SARS-CoV-2 infected patients.

Method

In CognitiVID study, 13 SARS-CoV-2-infected people were enrolled and evaluated at baseline and follow-up. Utilizing standardized cognitive assessments, patients were assessed at baseline and at 3 months follow-up. The evolution of the Montgomery and Asberg Depression Scale (MADRS), Dubois five words test, oral naming test, Frontal Assessment Battery (FAB), and Mini Mental State Evaluation (MMSE) was the major outcome ascertained.

Result

All patients had cognitive decline at baseline. However, at 3 months, improvement was observed on 2 out of 5 global tests following Bonferroni correction for multiple testing, as depicted in Table 1:

Conclusion

Intensive care for three months was associated with cognition improvement in SARS-CoV-2 infected people.

Source:

Revue Neurologique

Article:

Prevalence and prospective evaluation of cognitive dysfunctions after SARS due to SARS-CoV-2 virus. The COgnitiVID study

Authors:

C.Vialatte de Pémille et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: